0000947871-23-000779.txt : 20230725
0000947871-23-000779.hdr.sgml : 20230725
20230725165141
ACCESSION NUMBER: 0000947871-23-000779
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230725
DATE AS OF CHANGE: 20230725
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Galecto, Inc.
CENTRAL INDEX KEY: 0001800315
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371957007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39655
FILM NUMBER: 231109262
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 45-70-70-52-10
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Galecto Inc.
DATE OF NAME CHANGE: 20200116
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORBIMED ADVISORS LLC
CENTRAL INDEX KEY: 0001055951
IRS NUMBER: 133976876
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
144
1
primary_doc.xml
144
0001055951
XXXXXXXX
LIVE
0001800315
Galecto, Inc.
001-39655
75 State Street
Suite 100
Boston
MA
02109
45-70-70-52-10
OrbiMed Genesis Master Fund, L.P.
Shareholder
Common Stock
Bank of America
One Bryant Park
New York
NY
10036
7800
18330.00
25673474
07/25/2023
Nasdaq Stock Market
Common Stock
09/25/2020
Private placement
Issuer
N
7800
09/25/2020
Cash
N
OrbiMed Genesis Master Fund, L.P.
601 Lexington Ave.
54th Floor
New York
NY
10022
Common Stock
07/13/2023
9800
23520.00
OrbiMed Genesis GP LLC is the general partner of OrbiMed Genesis Master Fund, L.P. OrbiMed Advisors LLC is the managing member of OrbiMed Genesis GP LLC.
07/25/2023
/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors LLC, managing member of the general partner of OrbiMed Genesis Master Fund, L.P.